EARLY RESPONSE TO GLEPAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IN SHORT BOWEL SYNDROME PATIENTS WITH INTESTINAL FAILURE: RESULTS OF 24-WEEK PHASE 3 TRIAL
Tim Vanuytsel 1
Ulrich-Frank Pape 2
Sukanya Subramanian 3
Francisca Joly 4
Geert J.A. Wanten 5
Georg Lamprecht 6
Marek Kunecki 7
Faqooq Rahman 8
Thor Schutt Svane Nielsen 9
Lykke Bjerglund Graff 9
Mark Berner-Hansen 9
David F Mercer 10
Palle Bekker Jeppesen 11
1 University Hospital, Leuven, Belgium
2 Asklepios Medical School, Berlin, Germany
3 MedStar Georgetown, Washington DC, United States
4 Hospital Beaujon, Clichy, France
5 Radboud University Nijmegen Medical Centre (Radboud UMCN), Nijmegen, Netherlands
6 University Medical Center Rostock, Rostock, Germany
7 M. Pirogow Hospital, Wolczanska, Poland
8 University College London Hospitals (UCLH), London, United Kingdom
9 Zealand Pharma A/S, Copenhagen, Denmark
10 Nebraska Medical Center, Nebraska, United States
11 Rigshospitalet, Copenhagen, Denmark
Topic
Hepatobiliary, IBD, Small Intestine & Nutrition
Conference
UEG Week Copenhagen 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]